Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Assembly and transport mechanism of tripartite drug efflux systems

(2009) Rajeev Misra et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan

(2009) Farhat Ullah et al.   BURNS

Determination of the Efflux Pump-Mediated Resistance Prevalence in Pseudomonas aeruginosa, Using an Efflux Pump Inhibitor

(2009) Abolghasem Tohidpour et al.   CURRENT MICROBIOLOGY

Prospects for the next anti-Pseudomonas drug

(2009) Malcolm GP Page et al.   CURRENT OPINION IN PHARMACOLOGY

Functional interaction sites of OprM with MexAB in thePseudomonas aeruginosamultidrug efflux pump

(2009) Eisaku Yoshihara et al.   FEMS MICROBIOLOGY LETTERS

Flagellum-Mediated Biofilm Defense Mechanisms of Pseudomonas aeruginosa against Host-Derived Lactoferrin

(2009) J. G. Leid et al.   INFECTION AND IMMUNITY

Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa

(2009) Yoichi Hirakata et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa

(2009) Neda Gorgani et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pseudomonas aeruginosa – a phenomenon of bacterial resistance

(2009) Tanya Strateva et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Use of resazurin to detect mefloquine as an efflux-pump inhibitor in Pseudomonas aeruginosa and Escherichia coli

(2009) Faustino Vidal-Aroca et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosa

(2008) M. Sugimura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump

(2008) K. Jeannot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the MexAB-OprM Efflux Pump of Pseudomonas aeruginosa in Tolerance to Tea Tree (Melaleuca alternifolia) Oil and Its Monoterpene Components Terpinen-4-ol, 1,8-Cineole, and  -Terpineol

(2008) C. J. Papadopoulos et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria

(2008) Jean-Marie Pagès et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps

(2008) Siegbert Rieg et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics

(2008) L. Zhang et al.   JOURNAL OF BACTERIOLOGY

The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism

(2008) H. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA